Related Experiment Video
Updated: Apr 6, 2026
Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
CDKN3 knockdown reduces cell proliferation, invasion and promotes apoptosis in human ovarian cancer
Li-Ping Zhang1, Wen-Juan Li2, Yuan-Fang Zhu2
1Department of Ultrasound, Jiangxi Children's Hospital China.
Abstract:
Cyclin-dependent kinase inhibitor 3 (CDKN3) has been reported to promote tumor genesis. The aim of this study is to investigate the possible mechanisms of silence of CDKN3 exerting the suppressive role on epithelial ovarian cancer (EOC). To study the potential function of CDKN3 enrolled in the regulation of ovarian tumor, we monitored the EOC cells SKOV3 and HO8910 behaviors including proliferation, cell cycle, apoptosis and invasion. First, we found that CDKN3 was frequently over-expressed in EOC. Functional studies showed that silence of CDKN3 inhibited cancer cell proliferation by promoting cell cycle progression in G1 phase, decreased cell invasion and promoted EOC cells apoptosis. Western blot analysis of CDKN3-silence cells revealed down-regulation of DNA-replication and cell cycle related proteins. And, a significant correlation level of CDKN3 was observed which has been demonstrated to be a novel oncogene. These findings indicated that CDKN3 might serve as a useful potential target for treatment of ovarian cancer.
Insights
Cyclin-dependent kinase inhibitor 3 (CDKN3) promotes epithelial ovarian cancer (EOC) growth. Silencing CDKN3 inhibits EOC proliferation and invasion, offering a potential therapeutic target for ovarian cancer.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Cyclin-dependent kinase inhibitor 3 (CDKN3) is implicated in promoting tumor genesis.
- Understanding CDKN3's role in epithelial ovarian cancer (EOC) is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the mechanisms by which CDKN3 silencing suppresses epithelial ovarian cancer (EOC).
- To evaluate the functional impact of CDKN3 on EOC cell behaviors.
Main Methods:
- Monitoring EOC cell lines (SKOV3, HO8910) proliferation, cell cycle, apoptosis, and invasion.
- Utilizing Western blot analysis to assess protein expression changes in CDKN3-silenced cells.
Main Results:
- CDKN3 is frequently over-expressed in EOC.
- CDKN3 silencing inhibited EOC cell proliferation by promoting G1 phase cell cycle progression.
- Silencing CDKN3 decreased cell invasion and promoted apoptosis in EOC cells.
- Western blot revealed down-regulation of DNA-replication and cell cycle-related proteins upon CDKN3 silencing.
Conclusions:
- CDKN3 functions as an oncogene in EOC.
- CDKN3 silencing exhibits suppressive effects on EOC progression.
- CDKN3 represents a potential therapeutic target for ovarian cancer treatment.
Related Concept Videos
02:34Inhibition of Cdk Activity
02:34Inhibition of CDK Activity
02:15M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...